Models of comprehensive multidisciplinary care for individuals in the united states with genetic disorders

Pediatrics

Volumn 123, Issue 1, 2009, Pages 407-412

  Grosse, Scott D ^a   Schechter, Michael S ^b   Kulkarni, Roshni ^a   Lloyd Puryear, Michele A ^c   Strickland, Bonnie ^c   Trevathan, Edwin ^a,d  

^a NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Health Resources and Services Administration   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Care coordination; Genetic services; Health care disparities; Health care utilization

Indexed keywords

CHELATING AGENT; HYDROXYUREA;

ARTICLE; CHELATION THERAPY; CLINICAL EVALUATION; CYSTIC FIBROSIS; DISEASE CONTROL; GENETIC DISORDER; HEMOPHILIA; HUMAN; IRON OVERLOAD; POPULATION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; SICKLE CELL ANEMIA; TREATMENT OUTCOME; UNITED STATES; BIOLOGICAL MODEL; HEALTH CARE; INTERDISCIPLINARY COMMUNICATION; METHODOLOGY; REVIEW;

COMPREHENSIVE HEALTH CARE; GENETIC DISEASES, INBORN; HUMANS; INTERDISCIPLINARY COMMUNICATION; MODELS, GENETIC; UNITED STATES;

EID: 59449086020     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2007-2875     Document Type: Article

References (49)

1. Institute of Medicine. Crossing the Quality Chasm: A New Health System for the 21st Century. Washington, DC: National Academies Press; 2001
2. Wagner EH, Austin BT, Davis C, Hindmarsh M, Schaefer J, Bonomi A. Improving chronic illness care: translating evidence into action. Health Aff(Millwood). 2001;20(6):64-78
3. Sia C, Tonniges TF, Osterhus E, Taba S. History of the medical home concept. Pediatrics. 2004;113(5 suppl):1473-1478
4. Austin B, Wagner E, Hindmarsh M, Davis C. Elements of effective chronic care: a model for optimizing outcomes for the chronically ill. Epilepsy Behav. 2000;1(4):S15-S20
5. Baker JR, Crudder SO, Riske B, Bias V, Forsberg A. A model for a regional system of care to promote the health and well-being of people with rare chronic genetic disorders. Am J Public Health. 2005;95(11):1910-1916
6. Kuhlthau K, Ferris TG, Beal AC, Gortmaker SL, Perrin JM. Who cares for Medicaid-enrolled children with chronic conditions? Pediatrics. 2001;108(4):906-912
7. Kuhlthau K, Nyman RM, Ferris TG, Beal AC, Perrin JM. Correlates of use of specialty care. Pediatrics. 2004;113(3). Available at: www.pediatrics.org/cgi/content/full/113/3/e249
8. Cooley WC. Redefining primary pediatric care for children with special health care needs: the primary care medical home. Curr Opin Pediatr. 2004;16(6):689-692
9. Beal AC, Doty MM, Hernandez SE, Shea KK, Davis K. Closing the Divide: How Medical Homes Promote Equity in Health Care: Results From the Commonwealth Fund 2006 Health Care Quality Survey. New York, NY: Commonwealth Fund; 2007. Available at: www.commonwealthfund.org/publications/publicationsshow.htm?doc- id=50681. Accessed August 20, 2007
10. Wagner EH, Grothaus LC, Sandhu N, et al. Chronic care clinics for diabetes in primary care: a system-wide randomized trial. Diabetes Care. 2001;24(4):695-700
11. American Academy of Pediatrics, Council on Children with Disabilities. Care coordination in the medical home: integrating health and related systems of care for children with special health care needs. Pediatrics. 2005;116(5):1238-1244
12. Stille CJ, Antonelli RC. Coordination of care for children with special health care needs. Curr Opin Pediatr. 2004;16(6):700-705
13. Evatt BL. The natural evolution of haemophilia care: developing and sustaining comprehensive care globally. Haemophilia. 2006;12(suppl 3):13-21
14. Goldson E, Louch G, Washington K, Scheu H. Guidelines for the care of the child with special health care needs. Adv Pediatr. 2006;53:165-182
15. Lane PA. Sickle cell disease. Pediatr Clin North Am. 1996;43(3): 639-664
16. Bilenker JH, Weller WE, Shaffer TJ, Dover GJ, Anderson GF. The costs of children with sickle cell anemia: preparing for managed care. J Pediatr Hematol Oncol. 1998;20(6):528-533
17. Telfair J, Haque A, Etienne M, Tang S, Strasser S. Rural/urban differences in access to and utilization of services among people in Alabama with sickle cell disease. Public Health Rep. 2003; 118(1):27-36
18. Hoots WK. Comprehensive care for hemophilia and related inherited bleeding disorders: why it matters. Curr Hematol Rep. 2003;2(5):395-401
19. Levine PH. Delivery of healthcare inhemophilia. Ann NY Acad Sci. 1975;240:201-207
20. Manco-Johnson MJ, Riske B, Kasper CK. Advances in care of children with hemophilia. Semin Thromb Hemost. 2003;29(6):585-554
21. Smith PS, Keyes NC, FormanEN. Socioeconomic evaluation of a state-funded comprehensive hemophilia-care program. NEnglJMed. 1982;306(10):575-579
22. Soucie JM, Nuss R, Evatt B, et al. Mortality among males with hemophilia: relations with source of medical care. Blood. 2000; 96(2):437-442
23. Soucie JM, Symons J IV, Evatt B, et al. Home-based factor infusion therapy and hospitalization for bleeding complications among males with haemophilia. Haemophilia. 2001;7(2):198 - 206
24. Soucie JM, Cianfrini C, Janco RL, et al. Joint range-of-motion limitations among young males with hemophilia: prevalence and risk factors. Blood. 2004;103(7):2467-2473
25. National Hemophilia Foundation. Standards and Criteria for the Care of Persons With Congenital Bleeding Disorders. New York, NY:National Hemophilia Foundation; 2002. MASAC Recommendation 132. Available at:www.hemophilia.org/NHFWeb/MainPgs/MainNHF.aspx?menuid=57 & contentid=220. Accessed January 22, 2007
26. Centers for Disease Control and Prevention. Universal Data Collection project. Available at: www.cdc.gov/ncbddd/hbd/surveillance.htm#UDC. Accessed January 22, 2007
27. Dunn AL. Management and prevention of recurrent hemar-throsis in patients with hemophilia. Curr Opin Hematol. 2005;12(5):390-394
28. Cystic Fibrosis Foundation, Center Committee and Guidelines Subcommittee. Cystic Fibrosis Foundation guidelines for patient services, evaluation, and monitoring in cystic fibrosis centers. Am J Dis Child. 1990;144(12):1311-1312
29. Littlewood JM. Good care for people with cystic fibrosis. Pae-diatr Respir Rev. 2000;1(2):179-189
30. Cystic Fibrosis Foundation. Cystic Fibrosis Foundation Patient Registry, 2003 Annual Data Report. Bethesda, MD: Cystic Fibrosis Foundation; 2004
31. Morgan WJ, Butler SM, Johnson CA, et al. Epidemiologic study of cystic fibrosis: design and implementation of a prospective, multicenter, observational study of patients with cystic fibrosis in the US and Canada. Pediatr Pulmonol. 1999;28(4): 231-241
32. Schechter MS, Margolis P. Improving subspecialty healthcare: lessons from cystic fibrosis. J Pediatr. 2005;147(3):295-301
33. Johnson C, Butler SM, Konstan MW, Morgan W, Wohl ME. Factors influencing outcomes in cystic fibrosis: a center-based analysis. Chest. 2003;123(1):20-27
34. Padman R, McColley SA, Miller DP, et al. Infant care patterns at Epidemiologic Study of Cystic Fibrosis sites that achieve superior childhood lung function. Pediatrics. 2007;119(3).Available at: www.pediatrics.org/ cgi/content/full/119/3/e531
35. American Academy of Pediatrics, Section on Hematology/ Oncology, Committee on Genetics. Health supervision for children with sickle cell disease. Pediatrics. 2002;109(3):526-535
36. National Institutes of Health. The Management ofSickle Cell Disease. 4th ed. Bethesda, MD: National Institutes of Health; 2002. NTH Publication 02-2117. Available at: www.nhlbi.nih.gov/ health/prof/blood/sickle/ sc-mngt.pdf. Accessed February 4, 2006
37. Okpala I, Thomas V, Westerdale N, et al. The comprehensiveness care of sickle cell disease. Eur J Haematol. 2002;68(3): 157-162
38. Claster S, Vichinsky EP. Managing sickle cell disease. BMJ. 2003;327(7424):1151-1155
39. Mehta SR, Afenyi-Annan A, Byrns PJ, Lottenberg R. Opportunities to improve outcomes in sickle cell disease. Am Fam Physician. 2006;74(2):303-310
40. Smith LA, Oyeku SO, Homer C, Zuckerman B. Sickle cell disease: a question of equity and quality. Pediatrics. 2006; 117(5):1763-1770
41. Stinson J, Naser B. Pain management in children with sickle cell disease. Paediatr Drugs. 2003;5(4):229-241
42. Nietert PJ, Silverstein MD, Abboud MR. Sickle cell anaemia:epidemiology and cost of illness. Pharmacoeconomics. 2002; 20(6):357-366
43. Vichinsky E. New therapies in sickle cell disease. Lancet. 2002; 360(9333):629-631
44. Mitchell MB, Lambright WD, Breish R, et al. Meeting the challenge of managing vaso-occlusive crisis. J Healthc Qual. 2002;24(3):4-8, 56
45. Jamison C, Brown HN. A special treatment program for patients with sickle cell crisis. Nurs Econ. 2002;20(3):126-132
46. Vichinsky EP. Comprehensive care in sickle cell disease: its impact on morbidity and mortality. Semin Hematol. 1991;28(3): 220-226
47. Haque A, Telfair J. Socioeconomic distress and health status:the urban-rural dichotomy of services utilization for people with sickle cell disorder in North Carolina. J Rural Health. 2000;16(1):43-55
48. Hilliard LM, Maddox MH, Tang S, Howard TH. Development of a regionalized, comprehensive care network for pediatric sickle cell disease to improve access to care in a rural state. Dis Manage Health Outcomes. 2004;12(6):393-398
49. Shankar SM, Arbogast PG, Mitchel E, Ding H, Wang WC, Griffin MR. Impact of proximity to comprehensive sickle cell center on utilization of healthcare services among children with sickle cell disease. Pediatr Blood Cancer. 2008;50(1):66-71